UIMC1 contains tandem ubiquitin-interacting motifs (UIMs) that bind Lys-63-linked polyubiquitin chains at DNA damage sites, recruiting BRCA1-BARD1 complexes to double-strand breaks (DSBs) . Key features include:
Molecular Weight: ~80 kDa (calculated), with observed bands between 61–97 kDa due to post-translational modifications .
Domains: Two UIMs (residues 161–235 and 567–601) critical for ubiquitin binding .
Pathways: DNA damage repair, BRCA1-A complex assembly, and regulation of homologous recombination .
Biotinylation involves chemically linking biotin to antibodies, enabling detection via streptavidin-enzyme or streptavidin-fluorophore systems. For UIMC1 antibodies, this process enhances sensitivity through signal amplification .
Applications:
Benefits:
UIMC1 biotin-conjugated antibodies enable precise tracking of BRCA1-A complex dynamics:
BRCA1 Recruitment: UIMC1-bound antibodies highlight BRCA1 sequestration at DSBs, promoting non-homologous end joining (NHEJ) over homologous recombination (HR) .
Ubiquitination Analysis: Detects Lys-63-linked ubiquitin chains on histones H2A/H2AX during damage repair .
| Parameter | Details | Source |
|---|---|---|
| Host Species | Rabbit (polyclonal) | |
| Target Epitope | C-terminal region (AA 567–601) | |
| Cross-Reactivity | Human, mouse | |
| Detection Limit | ≤1 ng of UIMC1 in WB (using streptavidin-HRP) |
Buffer Compatibility: PBS with 0.02% sodium azide; avoid reducing agents to preserve biotin integrity .
Controls: Use unconjugated UIMC1 antibodies or isotype-matched biotinylated antibodies to validate specificity .
Biotin Interference: High endogenous biotin (e.g., in egg yolk or serum) may require blocking steps .
In BRCA1-Y1853ter mutants, UIMC1 interactions are disrupted, altering BRCA1-A complex localization. Biotin-conjugated UIMC1 antibodies quantified reduced binding affinity (mutant BRCA1 levels: 32.4% of WT) . This highlights their utility in profiling cancer-associated BRCA1 variants.